LPCN LPCN

Lipocine Stock Price

0.9491
0.0321 (3.5%)
Upgrade to Real-Time
Regular Market
0.9491
Volume 214,834
Bid Price 0.9268
Ask Price 0.9496
News -
Day High 0.9596

Low
0.8032

52 Week Range

High
2.36

Day Low 0.9021
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Lipocine Inc LPCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0321 3.5% 0.9491 12:21:15
Open Price Low Price High Price Close Price Prev Close
0.9098 0.9021 0.9596 0.917
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
735 214,834 $ 0.9385841 $ 201,640 - 0.8032 - 2.36
Last Trade Time Type Quantity Stock Price Currency
12:21:15 100 $ 0.9491 USD

Period:

Draw Mode:

Lipocine Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 83.80M 88.29M 86.15M $ - $ - -0.40 -4.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 326.00k 3.50%

more financials information »

Lipocine News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LPCN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.960.99990.80320.9209188607,423-0.0109-1.14%
1 Month1.041.130.80321.00598,469-0.0909-8.74%
3 Months1.071.220.80321.08615,940-0.1209-11.3%
6 Months1.321.500.80321.19705,634-0.3709-28.1%
1 Year2.312.360.80321.601,645,462-1.36-58.91%
3 Years1.613.500.3011.451,502,853-0.6609-41.05%
5 Years3.535.330.3011.581,031,705-2.58-73.11%

Lipocine Description

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.


Your Recent History
NASDAQ
LPCN
Lipocine
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.